Australian Clinical Labs Ltd (AU:ACL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
KKR Entities, including Comet Asia Holdings and KKR Asia III Fund, have become significant shareholders in Australian Clinical Labs Ltd, acquiring a 5.12% voting power through over 10 million fully paid ordinary shares. This development marks a notable investment move, potentially impacting the company’s future market dynamics.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.